StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report released on Wednesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance ATHX opened at $0.00 on Wednesday. Athersys has a twelve month low of $0.01 and a twelve month high of $1.99. The firm […]